Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
GSK
Pharma
GSK sets $35 out-of-pocket price cap for its inhalers in the US
The drugmaker's commitment will start by January 1, 2025 and follows similar moves by peers Boehringer Ingelheim and AstraZeneca.
Zoey Becker
Mar 21, 2024 11:45am
'Greedy' GSK is under fire from the AIDS Healthcare Foundation
Mar 18, 2024 12:23pm
AZ, GSK make case for broad I-O uses in endometrial cancer
Mar 18, 2024 11:05am
AstraZeneca caps out-of-pocket inhaler costs at $35 in the US
Mar 18, 2024 11:02am
GSK doubles funding for adult vaccine uptake programs
Mar 8, 2024 11:55am
With GSK's 2nd Blenrep win, analysts see blockbuster comeback
Mar 7, 2024 10:14am